Human herpesvirus 7 and the risk of developing multiple sclerosis

Area of Science:

• Neuroimmunology
• Virology
• Epidemiology

Background:

• Epstein-Barr virus is a known multiple sclerosis (MS) risk factor.
• Cytomegalovirus and human herpesvirus 6A are also implicated in MS etiology.
• The role of human herpesvirus 7 (HHV-7) in MS remains unclear.

Purpose of the Study:

• To investigate the association between HHV-7 infection and the risk of developing MS.
• To explore potential synergistic interactions between HHV-7 and Epstein-Barr virus (EBV) in MS risk.

Main Methods:

• A large-scale nested case-control study using Swedish registries and biobanks.
• Serological testing via multiplex immunoassay on blood samples from 981 MS cases and 1278 controls.
• Conditional logistic regression analysis to determine odds ratios and confidence intervals.

Main Results:

• Serological evidence of HHV-7 infection was associated with a significantly higher risk of developing MS (OR = 2.2, 95% CI = 1.8-2.7).
• This association persisted after adjusting for cytomegalovirus, EBV, and human herpesvirus 6A serostatus.
• Synergistic interactions were observed between HHV-7 and EBV nuclear antigen 1 seroreactivity regarding MS risk.

Conclusions:

• HHV-7 infection may be a contributing factor in the multifactorial etiology of MS.
• The findings suggest a potential interplay between different human herpesviruses in MS pathogenesis.
• Further research is warranted to elucidate the mechanisms underlying HHV-7's role in MS.